Plunkett Research Online: Biotie Therapies Oyj

BIOTIE THERAPIES OYJ (BIOZF:GREY) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Biotie Therapies Corp is a biopharmaceutical company engaged in products for neurodegenerative and psychiatric disorders. Its product portfolio includes Selincro, Tozadenant, SYN120 and BTT1023......



Biotie Therapies Oyj
Ticker: BIOZF
Exchange: GREY
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 358 22748900
Fax: 358 22748910
Address: Joukahaisenkatu 6
Turku, 20520 Finland

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceutical Preparation Manufacturing
ContactsDescription
David CookCFO
William BurnsChairman of the Board/Director
See More
Biotie Therapies Corp is a biopharmaceutical company engaged in products for neurodegenerative and psychiatric disorders. Its product portfolio includes Selincro, Tozadenant, SYN120 and BTT1023......See More See More

Auditor: PricewaterhouseCoopers
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201520142013201220112010
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: